Literature DB >> 17850872

Spatial distribution of histone methylation during MHC class II expression.

Shiuh-Dih Chou1, Thomas B Tomasi.   

Abstract

We have previously reported that Major Histocompatibility Complex (MHC) class II can be induced by histone deacetylase inhibitors (HDACi) in the absence of class II transactivator (CIITA). Here we characterized the histone modifications associated with the CIITA-dependent (IFN-gamma induced) and -independent (HDACi induced) MHC class II expression. We demonstrate that both IFN-gamma and HDACi induced MHC class II expression exhibited enhanced histone H3, H4 acetylation and H3K4me3 at the MHC class II promoter while H3K9me3 was decreased. In contrast, high levels of H3K36me3 were detected at exons 3 and 5 but not at the promoter or the locus control region (LCR). Interestingly, high levels of H3K79me2 were only detected at the promoter and exon 3 of the B cell lines while the level remained low and unchanged despite active MHC class II expression induced by either IFN-gamma or HDACi treatment. Constitutive expression of the CIITA protein by stable transfection of a CIITA deficient B cell line restored the H3K79me2 to a level comparable to its cell of origin. This data demonstrates that, although regulated by different pathways, both IFN-gamma and HDACi treatments resulted in similar patterns of histone modifications and that HDACi induce both histone methylation and acetylation. In addition, the different spatial distribution of the lysine methylation markers along the gene suggests that these modifications play a distinctive role during different phases of the transcription process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17850872      PMCID: PMC2185543          DOI: 10.1016/j.molimm.2007.07.039

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  42 in total

1.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

2.  Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250.

Authors:  A Raval; T K Howcroft; J D Weissman; S Kirshner; X S Zhu; K Yokoyama; J Ting; D S Singer
Journal:  Mol Cell       Date:  2001-01       Impact factor: 17.970

Review 3.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 4.  Histone acetylation and an epigenetic code.

Authors:  B M Turner
Journal:  Bioessays       Date:  2000-09       Impact factor: 4.345

5.  SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.

Authors:  David C Schultz; Kasirajan Ayyanathan; Dmitri Negorev; Gerd G Maul; Frank J Rauscher
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

6.  The Set2 histone methyltransferase functions through the phosphorylated carboxyl-terminal domain of RNA polymerase II.

Authors:  Bing Li; LeAnn Howe; Scott Anderson; John R Yates; Jerry L Workman
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

Review 7.  Epigenetic regulation of MHC-II and CIITA genes.

Authors:  Kenneth L Wright; Jenny P-Y Ting
Journal:  Trends Immunol       Date:  2006-07-25       Impact factor: 16.687

8.  CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter.

Authors:  G W Beresford; J M Boss
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

9.  Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors.

Authors:  W J Magner; A L Kazim; C Stewart; M A Romano; G Catalano; C Grande; N Keiser; F Santaniello; T B Tomasi
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

10.  A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.

Authors:  Joanna Wysocka; Tomek Swigut; Hua Xiao; Thomas A Milne; So Yeon Kwon; Joe Landry; Monika Kauer; Alan J Tackett; Brian T Chait; Paul Badenhorst; Carl Wu; C David Allis
Journal:  Nature       Date:  2006-05-21       Impact factor: 49.962

View more
  6 in total

1.  Regulation of acetylation at the major histocompatibility complex class II proximal promoter by the 19S proteasomal ATPase Sug1.

Authors:  Olivia I Koues; R Kyle Dudley; Agnieszka D Truax; Dawson Gerhardt; Kavita P Bhat; Sam McNeal; Susanna F Greer
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

Review 2.  MHC class II regulation by epigenetic agents and microRNAs.

Authors:  Thomas B Tomasi; William J Magner; Jennifer L Wiesen; Julian Z Oshlag; Felicia Cao; Alex N Pontikos; Christopher J Gregorie
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

3.  Roles for common MLL/COMPASS subunits and the 19S proteasome in regulating CIITA pIV and MHC class II gene expression and promoter methylation.

Authors:  Olivia I Koues; Ninad T Mehta; Agnieszka D Truax; R Kyle Dudley; Jeanne K Brooks; Susanna F Greer
Journal:  Epigenetics Chromatin       Date:  2010-02-04       Impact factor: 4.954

4.  Multiple histone methyl and acetyltransferase complex components bind the HLA-DRA gene.

Authors:  Nancy M Choi; Jeremy M Boss
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

5.  MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.

Authors:  B Vagaska; S E P New; C Alvarez-Gonzalez; F D'Acquisto; S G Gomez; N W Bulstrode; A Madrigal; P Ferretti
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

6.  Expression regulation of major histocompatibility complex class I and class II encoding genes.

Authors:  Peter J van den Elsen
Journal:  Front Immunol       Date:  2011-10-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.